# Safety and efficacy of an olive oil-based triple-chamber bag for parenteral nutrition: a prospective, randomized, multi-center clinical trial in China

**Authors:** Zhen-Yi Jia, Jun Yang, Yang Xia, Da-Nian Tong, Gary P. Zaloga, Huan-Long Qin

PMC · DOI: 10.1186/s12937-015-0100-6 · Nutrition Journal · 2015-11-14

## TL;DR

A study in China found that an olive oil-based parenteral nutrition regimen was as effective as a soybean oil-based one and caused fewer infections.

## Contribution

This is the first large multi-center trial comparing olive oil-based and soybean oil-based parenteral nutrition in Chinese adults.

## Key findings

- Olive oil-based nutrition was not inferior to soybean oil-based in improving anabolic status.
- Olive oil-based nutrition was associated with significantly fewer infections.
- Olive oil-based nutrition was easier to use and better tolerated.

## Abstract

Small studies suggest differences in efficacy and safety exist between olive oil-based (OLIVE) and soybean oil-based (SOYBEAN) parenteral nutrition regimens in hospitalized adult patients. This large, prospective, randomized (1:1), open-label, multi-center, noninferiority study compared the delivery, efficacy, and safety of OLIVE (N = 226) with SOYBEAN (N = 232) in Chinese adults (≥18 years) admitted to a surgical service for whom parenteral nutrition was required.

Treatments were administered for a minimum of 5 days up to 14 days (to achieve approximately 25 kcal/kg/day, 0.9 g/kg/day amino acids, 0.8 g/kg/day lipid). Impact of treatment on anabolic/catabolic and serum inflammatory, chemistry, and hematological markers, safety, and ease of use were assessed. The primary efficacy variable was serum prealbumin level at Day 5.

OLIVE (n = 219) was not inferior to SOYBEAN (n = 224) based on the prealbumin least square geometric mean [LSGM] ratio [95 % CI] 1.12 [1.06, 1.19]; P = 0.002), improved the anabolic/catabolic status of patients enrolled in the study, and was well tolerated compared with SOYBEAN. Improved anabolic status was supported by significantly higher levels of prealbumin at Day 5, albumin at Day 5 and IGF-1 at Day 14 in the OLIVE group, while catabolism was similar between groups. C-reactive protein, intercellular adhesion molecule-1, procalcitonin, and oxidation were similar in each group, but infections were significantly lower with OLIVE (3.6 % versus 10.4 %; P < 0.01).

OLIVE provided effective nutrition, was well tolerated, was associated with fewer infections, and conferred greater ease-of-use than SOYBEAN.

NTC 01579097.

## Linked entities

- **Proteins:** Ttr (transthyretin), LOC100189571 (uncharacterized LOC100189571), IGF1 (insulin like growth factor 1)

## Full-text entities

- **Genes:** IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}
- **Diseases:** Pyrexia (MESH:D005334), epistaxis (MESH:D004844), PN (MESH:D044342), blood stream infections (MESH:D000086982), Incision (MESH:D000072836), Inflammation (MESH:D007249), CI (OMIM:610141), of plasma (MESH:D054219), intestinal fistula (MESH:D007412), nutrition disorders (MESH:D009748), wound infections (MESH:D014946), hypernatremia (MESH:D006955), cardiopulmonary failure (MESH:D051437), lipid abnormalities (MESH:D011017), tachypnea (MESH:D059246), tissue injury (MESH:D017695), ureteric fistula (MESH:D014515), leukocytosis (MESH:D007964), hypovolemic shock (MESH:D012769), tenderness (MESH:D063806), Urinary tract infections (MESH:D014552), Nausea (MESH:D009325), congestive heart failure (MESH:D006333), Gastrointestinal disorders (MESH:D005767), incision site infections (MESH:D013530), liver dysfunction/failure (MESH:D017093), Abdominal/gastrointestinal infections (MESH:D000007), purulent sputum (MESH:D003234), pain (MESH:D010146), Infection (MESH:D007239), dyslipidemia (MESH:D050171), OLIVE (MESH:C564931), tachycardia (MESH:D013610), hyperglycemia (MESH:D006943), impaired hepatic function (MESH:D008107), hypersensitivity (MESH:D004342), congenital abnormalities of amino acid metabolism (MESH:D000592), muscle weakness (MESH:D018908), Bloodstream infections (MESH:D018805), Swelling (MESH:D004487), Cholestasis (MESH:D002779), vomiting (MESH:D014839), scrotum (MESH:C537770), pneumonia (MESH:D011014), Vascular disorders (MESH:D002561), human immunodeficiency virus infection (MESH:D015658), trauma (MESH:D014947), critically ill (MESH:D016638), Phlebitis (MESH:D010689), acute myocardial infarction (MESH:D009203), Peripheral vascular disorder (MESH:D016491), Lung infections (MESH:D012141), mITT (MESH:D014202), Hypokalemia (MESH:D007008), pharyngeal hemorrhage (MESH:D010612), acute renal failure (MESH:D058186), died (MESH:D003643), SAEs (MESH:D064420), Events (MESH:D002318), Hepatobiliary disorder (MESH:D004066)
- **Chemicals:** phosphate (MESH:D010710), Lipid (MESH:D008055), Phosphorus (MESH:D010758), 3-methylhistidine (MESH:C028118), sodium (MESH:D012964), blood glucose (MESH:D001786), Eicosapentaenoic Acid (MESH:D015118), Creatinine (MESH:D003404), calcium (MESH:D002118), bilirubin (MESH:D001663), chloride (MESH:D002712), Linoleic Acid (MESH:D019787), Cholesterol (MESH:D002784), Bicarbonate (MESH:D001639), amino acid (MESH:D000596), Soybean oil (MESH:D013024), Malondialdehyde (MESH:D008315), leukotrienes (MESH:D015289), Triglyceride (MESH:D014280), Arachidonic Acid (MESH:D016718), eicosanoid (MESH:D015777), MDA (MESH:D015104), 15-AA (-), F2-Isoprostane (MESH:D028441), nitrogen (MESH:D009584), Oleic Acid (MESH:D019301), PUFA (MESH:D005231), urea (MESH:D014508), Cortisol (MESH:D006854), magnesium (MESH:D008274), MUFA (MESH:D005229), urea nitrogen (MESH:C530477), water (MESH:D014867), olive oil (MESH:D000069463), D-glucose (MESH:D005947), fatty acid (MESH:D005227), Free Fatty Acid (MESH:D005230), omega-6 PUFA (MESH:D043371), MCT (MESH:C000709826), Intralipid (MESH:C545823), Potassium (MESH:D011188),  (MESH:D005217)
- **Species:** Glycine max (soybean, species) [taxon 3847], Homo sapiens (human, species) [taxon 9606], Olea europaea (common olive, species) [taxon 4146]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4647821/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4647821/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC4647821/full.md

---
Source: https://tomesphere.com/paper/PMC4647821